Proto-Oncogene Proteins

DBCAT000210Pharmacologic class

Products of proto-oncogenes. Normally they do not have oncogenic or transforming properties, but are involved in the regulation or differentiation of cell growth. A DrugBank category of 2 drugs. 1 of them is approved.

Also known as: c onc Proteins · c-onc Proteins · Cellular Proto Oncogene Proteins · Cellular Proto-Oncogene Products · Cellular Proto-Oncogene Proteins
Drugs: Becaplermin
Nelipepimut-S

What you can answer from here — as of August 24, 2016

2DrugsEach linked to its full drug card

Listed above

5Drug targetsEvery drug–target pair in the class, with bond type

7Marketed productsAcross the regions we cover, with dosage forms and routes

1Route of administrationHow the drugs in this class are given

Which targets do Proto-Oncogene Proteins share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account